circRNA basic information
circBase ID: -
Name: hsa_circ_SCMH1
Synonym: circSCMH1
Host Gene: SCMH1
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

fresh HCC specimens; SOR-resistant HCC tissues; tumor tissues

Cell lines:

Huh7; Hep3B; Huh7/SOR; Hep3B/SOR

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: HN1
Associated microRNA: miR-485-5p
Biological function: circSCMH1 promotes sorafenib resistance, cell proliferation, migration, invasion, and glucose metabolism, and inhibits apoptosis in sorafenib-resistant HCC cells; circSCMH1 depletion inhibits tumor growth and increases sorafenib sensitivity in vivo.
Molecular mechanism: circSCMH1 functions as a ceRNA by sponging miR-485-5p to upregulate HN1 expression, thereby promoting sorafenib resistance in HCC cells.
Biological pathway or process:

drug resistance (promotes); chemoresistance (promotes); proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); glycolysis (promotes); ceRNA regulation (other)

Detected method:
Q
Validation methods:

RT-qPCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); Transfection; CCK8; Colony Formation Assay; EdU Staining; Transwell Assay; Annexin V/PI Flow Cytometry; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry)

Clinical significance:

circSCMH1 is elevated in SOR-resistant HCC tissues and may provide a circRNA-targeted therapeutic strategy to overcome sorafenib resistance in HCC.

Description:

circSCMH1 is up-regulated in sorafenib-resistant HCC tissues and cells. It promotes sorafenib resistance and malignant phenotypes by acting as a ceRNA for miR-485-5p, thereby upregulating HN1; circSCMH1 knockdown increases sorafenib sensitivity in vitro and in a Huh7/SOR xenograft model.

Confidence score:

0.8443

Other information
Title:

CircSCMH1 Accelerates Sorafenib Resistance in Hepatocellular Carcinoma by Regulating HN1 Expression via miR-485-5p.

Journal: Molecular biotechnology
Published: 2025
PubMed ID: 38372878
Study type:

combined biological and clinical study

Data availability: The analyzed datasets generated during the present study are available from the corresponding author on reasonable request.
Code availability: -